1. Home
  2. WVE vs NTB Comparison

WVE vs NTB Comparison

Compare WVE & NTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVE
  • NTB
  • Stock Information
  • Founded
  • WVE 2012
  • NTB 1858
  • Country
  • WVE Singapore
  • NTB Bermuda
  • Employees
  • WVE N/A
  • NTB N/A
  • Industry
  • WVE Biotechnology: Pharmaceutical Preparations
  • NTB Commercial Banks
  • Sector
  • WVE Health Care
  • NTB Finance
  • Exchange
  • WVE Nasdaq
  • NTB Nasdaq
  • Market Cap
  • WVE 939.3M
  • NTB 1.7B
  • IPO Year
  • WVE 2015
  • NTB 2016
  • Fundamental
  • Price
  • WVE $6.54
  • NTB $41.00
  • Analyst Decision
  • WVE Strong Buy
  • NTB Buy
  • Analyst Count
  • WVE 11
  • NTB 4
  • Target Price
  • WVE $20.91
  • NTB $44.25
  • AVG Volume (30 Days)
  • WVE 1.7M
  • NTB 179.3K
  • Earning Date
  • WVE 05-08-2025
  • NTB 04-23-2025
  • Dividend Yield
  • WVE N/A
  • NTB 4.29%
  • EPS Growth
  • WVE N/A
  • NTB 7.68
  • EPS
  • WVE N/A
  • NTB 4.81
  • Revenue
  • WVE $104,939,000.00
  • NTB $585,277,000.00
  • Revenue This Year
  • WVE N/A
  • NTB N/A
  • Revenue Next Year
  • WVE N/A
  • NTB $0.79
  • P/E Ratio
  • WVE N/A
  • NTB $8.47
  • Revenue Growth
  • WVE N/A
  • NTB 1.89
  • 52 Week Low
  • WVE $4.25
  • NTB $32.78
  • 52 Week High
  • WVE $16.74
  • NTB $41.88
  • Technical
  • Relative Strength Index (RSI)
  • WVE 42.23
  • NTB 65.99
  • Support Level
  • WVE $6.30
  • NTB $40.33
  • Resistance Level
  • WVE $8.39
  • NTB $41.42
  • Average True Range (ATR)
  • WVE 0.66
  • NTB 0.86
  • MACD
  • WVE 0.10
  • NTB 0.23
  • Stochastic Oscillator
  • WVE 33.21
  • NTB 87.40

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About NTB Bank of N.T. Butterfield & Son Limited (The) Voting

Bank of N.T Butterfield & Son Ltd is a full-service bank and wealth manager. It operates the business through three geographic segments, Bermuda, Cayman Islands, the Channel Islands and the UK. The company offers banking services, comprised of retail and corporate banking, and wealth management, which consists of trust, private banking, and asset management. The company generates a majority of its revenue from Bermuda, and the Cayman Islands segments.

Share on Social Networks: